Shareholders Equity: The sum of preferred and common equity items.
Polaryx Therapeutics, Inc. (PLYX) had Shareholders Equity of $10.94M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.38M |
|
-- |
|
-- |
|
$1.38M |
|
$-1.38M |
|
-- |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
$-1.38M |
|
48.28M |
|
48.28M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$11.81M |
|
-- |
|
-- |
|
$11.81M |
|
$0.87M |
|
-- |
|
-- |
|
$0.87M |
|
$10.94M |
|
$10.94M |
|
|
Shareholders Equity |
$10.94M |
49.85M |
|
| Cash Flow Statement Financials | |
$-3.43M |
|
-- |
|
$9.83M |
|
$5.14M |
|
$11.54M |
|
$6.40M |
|
$0.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.62% |
|
-12.62% |
|
-11.68% |
|
-12.62% |
|
$0.22 |
|
$-0.07 |
|
$-0.07 |
|